ESCMID

The European Society of Clinical Microbiology and Infectious Diseases
Improving the diagnosis, treatment and prevention of infection-related diseases

[ESCMID @ESCMID]

⚖️ Last chance to join this online course to discuss real-world challenges in clinical practice, research, antimicrobial stewardship, One Health and infection control.

This is part of the AMS Cert Programme w/ limited spots left.

💡Register by 05 Nov: https://t.co/gjcJI19CWi

[ESCMID @ESCMID]

🔬 Join us at 15:00 CET for Part 1 of ESCMID's #WAAW2026 webinar series!

📺 Can't attend live? The recording will be available on ESCMID Media shortly after the webinar.

📅 Part 2 follows next Thursday!

👉 Register now & join us live! https://t.co/uJJmXNPXzG

#WAAW2026 #AMR

[ESCMID @ESCMID]

🎉 Registration for #ESCMIDGlobal2027 is now open!

🌍 Join us in Stockholm, 09–13 April 2027, for five days of scientific exchange, networking and the latest in clinical microbiology and infectious diseases.

👉 Register now: https://t.co/5dTjgM4eiF

[ESCMID @ESCMID]

🚨 New Epi Alert this week: France reports its first human Shamonda virus case, while Bundibugyo Ebola spreads beyond the DRC. West Nile virus is widespread across Europe, dengue is rising in parts of the Americas, and US measles cases continue.

🔎 https://t.co/1e0res3qdK

[ESCMID @ESCMID]

Help develop evidence-based guidelines and shape recommendations that support clinical practice in infectious diseases and clinical microbiology.

Accepting applications until 10 Nov 2026

👉 Learn more: https://t.co/TKgoO32VpU

[ESCMID @ESCMID]

📣 Open positions across ESCMID Subcommittees:

🔬Scientific Affairs
🚀 Professional Affairs
💡 Guidelines

Bring your expertise to ESCMID and help shape our activities.

Apply by 31 Oct: https://t.co/bALxAqqi1C

[ESCMID @ESCMID]

Learn how responsible antimicrobial use and effective infection control can help combat AMR.

This onsite course is part of the ESCMID AMS Certificate Programme, with limited spots open to other participants.

💡 Register today: https://t.co/KGhAtTr9py

[Clinical Microbiology and Infection @CMIJournal]

This Narrative Review provides an overview of E-values and the bounding factor, a relatively new metric to assess robustness to unmeasured confounding:
https://t.co/LwiEpB37U2

[ESCMID @ESCMID]

💉 ESCMID reaffirms its support for MMR vaccination and policies grounded in scientific evidence.

Read the statement by the ESCMID EC and Vaccines Subcommittee endorsed by SAS, EVASG, @IDSAInfo.

Published in
💡CMI: https://t.co/1ZVLQVmavf
💡CMI Comms: https://t.co/1fpk0QphgL

[ESCMID @ESCMID]

📣 We’re looking for the next director of the AMR Action Subcommittee! Member positions are also open for applications.

Help shape ESCMID’s activities addressing #AMR and take an active role in this critical area.

👉 Learn more & apply by 31 October: https://t.co/zapoHIgdTI

[ESCMID @ESCMID]

All three parts of the recent Bundibugyo ebolavirus vaccine webinar series are now available for replay for free.

Discover the programme: https://t.co/eqYGzB8XH9

Watch on ESCMID Media: https://t.co/NUTpH0luNM

[ESCMID @ESCMID]

Build your skills in managing high-burden infectious diseases! This online course covers tropical infections, HIV & TB, with practical, evidence-based approaches to diagnosis and management led by international experts.

Learn more & register today: https://t.co/V9mfQ0pPRa

[ESCMID @ESCMID]

Always great to take the opportunity of building stronger collaborations between @IDSAInfo and @ESCMID leadership teams especially during #IDWeek. The joint commitment to advancing the field of infectious diseases is a strong reminder that together we can achieve more.

[ESCMID @ESCMID]

🔬 Join our first #WAAW2026 webinar next Thurs, 29 Oct at 15:00 CET

Explore rapid & genomic diagnostics for emerging pathogens & #AMR.

👉 Discover the programme & register today: https://t.co/8gZxHtnCXn

[ESCMID @ESCMID]

🩺 Build your knowledge on STIs, a topic that deserves increasing attention.

Learn to recognise emerging trends and challenges, and how to integrate modern approaches to support effective treatment and strengthen prevention strategies.

Register today: https://t.co/JuRSPjo0DF

[ESCMID @ESCMID]

🚨 New Epi Alert this week: Bundibugyo Ebola updates from the DRC and beyond, rising measles in the Americas and dengue surges.

🦟 West Nile spreads north in Europe, while Côte d’Ivoire reports 23 yellow fever cases and 11 deaths.

👉 https://t.co/lfWOuZAoXP

[ESCMID @ESCMID]

🌍 Planning to attend #ESCMIDGlobal2027?

ESCMID offers grants to support researchers, clinicians and healthcare professionals from around the world.

📅 Apply by 18 November 2026!

👉 Discover funding opportunities and eligibility criteria on our website! https://t.co/TeRssNwjrM

[ESCMID @ESCMID]

📣 Open positions across ESCMID Subcommittees!

🔬Scientific Affairs
💉 Vaccines
🩺 Emerging Infections
🦠 AMR Action
🚀 Professional Affairs
🎓 Education
💡 Guidelines

Bring your expertise to ESCMID and help shape our activities.

Apply by 31 Oct: https://t.co/bALxAqqi1C

[ESCMID @ESCMID]

Build your knowledge of classical and emerging hepatitis viruses, from hepatitis A–E to viral haemorrhagic fevers including yellow fever, dengue & Crimean-Congo haemorrhagic fever.

A must for those interested in viral liver diseases.

Register today: https://t.co/loQ2ew5hjm

[Clinical Microbiology and Infection @CMIJournal]

Original article investigating the bidirectional associations between bacteraemia and CMV infection and their impact on transplantation outcomes, as well as the effect of LTV prophylaxis on these associations: https://t.co/6ql62iZ2bv